Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Baruchel

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Pharmacology|May 11, 1999
Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in childrenR Loebstein, G Atanackovic, R Bishai, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2006
Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumoursS Baruchel, M Diezi, D Hargrave, et al.
Nature Genetics|August 1, 1996
Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21N Rahman, L Arbour, P Tonin, et al.
Journal of Pediatric Hematology/Oncology|December 22, 1999
Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group studyM L Bernstein, S Baruchel, S Devine, et al.
Investigational New Drugs|January 1, 1995
A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group studyS Baruchel, M Bernstein, V M Whitehead, et al.
British Journal of Haematology|August 1, 1994
Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patientsD G Costagliola, M de Montalembert, J J Lefrère, et al.
The New England Journal of Medicine|October 17, 1991
Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-ChoriH E Witkowska, B H Lubin, Y Beuzard, et al.
Current Oncology (Toronto, Ont.)|February 19, 2011
The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour ConsortiumU Bartels, S Baruchel, A S Carret, et al.
Oncogene|April 14, 2009
Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastomaL M S Lau, J K Wolter, J T M L Lau, et al.
British Journal of Cancer|September 12, 2013
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancerR K Kelley, J Hwang, M J M Magbanua, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Pharmacology|May 11, 1999
Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in childrenR Loebstein, G Atanackovic, R Bishai, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2006
Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumoursS Baruchel, M Diezi, D Hargrave, et al.
Nature Genetics|August 1, 1996
Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21N Rahman, L Arbour, P Tonin, et al.
Journal of Pediatric Hematology/Oncology|December 22, 1999
Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group studyM L Bernstein, S Baruchel, S Devine, et al.
Investigational New Drugs|January 1, 1995
A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group studyS Baruchel, M Bernstein, V M Whitehead, et al.
British Journal of Haematology|August 1, 1994
Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patientsD G Costagliola, M de Montalembert, J J Lefrère, et al.
The New England Journal of Medicine|October 17, 1991
Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-ChoriH E Witkowska, B H Lubin, Y Beuzard, et al.
Current Oncology (Toronto, Ont.)|February 19, 2011
The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour ConsortiumU Bartels, S Baruchel, A S Carret, et al.
Oncogene|April 14, 2009
Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastomaL M S Lau, J K Wolter, J T M L Lau, et al.
British Journal of Cancer|September 12, 2013
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancerR K Kelley, J Hwang, M J M Magbanua, et al.
Pageof 4